Mereo BioPharma Group plc (MREO)
SEC filings, insider trading & institutional ownership from EDGAR.
Couldn’t find the data you were looking for?
We haven’t added Mereo BioPharma Group plc’s filings yet. We add companies and filings all the time.
Track MREO and we’ll email you the moment its filings are in, free and with no account. Or create a free account to request coverage.
Latest filings
10-K, 10-Q, 8-K, Form 4 & 13D/G. Sourced directly from SEC EDGAR
No filings are available yet.
Top holders
13F & 13D/G • latest quarter
| Holder | Filed | Value |
|---|---|---|
| BANK OF AMERICA CORP /DE/ | Aug 14, 2026 | $2.6B |
| MILLENNIUM MANAGEMENT LLC | May 15, 2026 | $1.17B |
| UBS Group AG | Aug 13, 2026 | $460.35M |
| TWO SIGMA INVESTMENTS, LP | Aug 14, 2026 | $419.12M |
| CITADEL ADVISORS LLC | Sep 1, 2026 | $317.72M |
MREO's filings are public. The insight is one click away.
Scrutar's AI reads every MREO filing and points out what matters. Red flags, risk shifts, disclosure quality and key relationships. Cited to the source, free with an account.
Never miss a MREO filing.
Get an email when MREO files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.
Free foreverNo account requiredOne-click unsubscribe
Data as of Oct 16, 2026Source: SEC EDGAR.